This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
September 30, 2021
Targovax ASA appoints Ola Melin as Head of Manufacturing
September 28, 2021
Fusion Pharmaceuticals Appoints Mohit Rawat As President And Chief Business Officer
September 28, 2021
BONESUPPORT – SUPPLEMENTARY US DENOVO APPLICATION SUBMITTED
September 24, 2021
Targovax granted European Patent for ONCOS-102 in combination with chemotherapy
September 23, 2021
Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.
September 22, 2021
CARISMA Therapeutics Announces U.S. Food and Drug Administration Grants Fast Track Designation to CT-0508 for the Treatment of Patients with Solid Tumors
September 22, 2021
Vicore obtains SARS coronavirus patent for C21 in the USA
September 22, 2021
Vicore to host Key Opinion Leader webinar on C21 for the treatment of idiopathic pulmonary fibrosis (IPF)
September 21, 2021
Pulmonx Announces Two Additional Significant Blue Cross Blue Shield Plans Now Provide Coverage for Severe Emphysema/COPD Treatment
September 21, 2021
Fusion Pharmaceuticals Appoints Eric S. Hoffman, Ph.D. As Senior Vice President, Business Development